GENE ONLINE|News &
Opinion
Blog

2026-05-04|

Pediatric SARS-CoV-2 Outcomes Study: 12-Month Data Reveals Post-COVID-19 Symptoms in Children

by GOAI
Share To

A recent longitudinal study followed a group of children for 12 months, comparing those who contracted SARS-CoV-2 with those who remained uninfected, to gather data on post-COVID-19 symptoms in children. The study, known as the Pediatric SARS-CoV-2 Outcomes Study (PECOS), provides comprehensive data on the long-term effects of the virus on pediatric populations.

Published in *Pediatric Research*, the PECOS study tracked children over a year to identify differences in health outcomes between infected and uninfected children. Researchers collected data on a range of symptoms and health indicators to understand the prevalence and duration of post-COVID conditions in children. The findings contribute to a better understanding of the long-term impact of COVID-19 on children’s health.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: May 3, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Ellomay Capital Completes Sale of Dorad Energy Holdings on May 10, 2026
2026-05-10
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10
India’s Pharmaceutical Growth Slows: Industry Needs New Strategies
2026-05-10
MoonLake Immunotherapeutics Concludes Pre-BLA Meeting with FDA and Reports Q1 2026 Financial Results
2026-05-10
New Method Allows Repeated Genetic Data Extraction From Living Cells Without Destruction
2026-05-10
Scroll to Top